Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty & Preceptor Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Glitazones

Glitazones

  • Diabetes (924)
    • Blood Glucose Meters (10)
    • Complications (205)
    • Diabetes in Pregnancy (12)
    • Diabetes Meds (89)
    • Drug-Induced Hypo/Hyperglycemia (141)
    • Monitoring (145)
    • Natural Medicines/Supplements (13)
    • Prevention (47)
    • Treatment (390)
      • Alpha-Glucosidase Inhibitors (27)
      • Amylin Agonist (20)
      • Bromocriptine (10)
      • Combination Products (23)
      • Gliptins (86)
      • Glitazones (129)
      • GLP-1 (42)
      • Incretin Enhancers/Mimetics (88)
      • Insulin (202)
      • Meglitinides (46)
      • Metformin (167)
      • SGLT2 Inhibitors (94)
      • Sulfonylureas (133)
      • Treatment of Pediatric Metabolic Syndrome (10)
  • Endocrinology (12)
  • Hyperglycemia (40)
  • Hypoglycemia (19)
  • Other (32)
  • Prediabetes (5)
  • Resources (277)
  • Thyroid Disorders (65)
106 - 120 of 129 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) May 2010
Article: which is the best drug to add to metformin for type 2 diabetes May 2010
Commentary: Avandia and Cardiovascular Safety: Ongoing Review April 2010
Other: Senate Concerns about Avandia April 2010
Article: Ongoing concerns about Avandia (rosiglitazone) April 2010
Article: whether Avandia (rosiglitazone) increases heart attack risk March 2010
Article: The ADA is dropping its recommendation for Avandia and now recommends a back-to-basics approach for treating type 2 diabetes December 2008
Guideline: 2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes December 2008
Commentary: Updated Treatment Recommendations for Type 2 Diabetes December 2008
Article: More type 2s are using insulin November 2008
Guideline: 2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes November 2008
Commentary: Insulin Use in Patients with Type 2 Diabetes November 2008
Guideline: ADA Position Statement on Standards of Medical Care in Diabetes - 2008 November 2008
Article: Does intensive blood-glucose lowering reduce the risk of cardiovascular disease in patients with type 2 diabetes August 2008
Guideline: CDA Clinical Practice Guidelines on Monitoring Glycemic Control August 2008
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved